VCYT
Veracyte Inc.
Company Overview
| Mkt Cap | $2.68B | Price | $36.29 |
| Volume | 284.97K | Change | +0.58% |
| P/E Ratio | 111.2 | Open | $35.97 |
| Revenue | $445.8M | Prev Close | $36.08 |
| Net Income | $24.1M | 52W Range | $22.61 - $47.32 |
| Div Yield | N/A | Target | $40.67 |
| Overall | 53 | Value | 40 |
| Quality | 60 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyVeracyte Inc. (VCYT) is a leading Healthcare company in the Biotechnology industry, currently trading at $36.08 with a market capitalization of $2.68 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows VCYT with a volume of 624K shares. The stock opened down 0.40% from yesterday's close of $35.33. Current analyst estimates project earnings of $0.88 per share for this year, with next year targeting $0.96.
VCYT demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including EXAS, BIOC, MYGN.
Key investment considerations for VCYT include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 12.7%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 09:22 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VCYT | $36.29 | +0.6% | 284.97K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |